Impax Laboratories, Inc.
IPXL
IPXL was delisted on the 4th of May, 2018.
178 hedge funds and large institutions have $2.04B invested in Impax Laboratories, Inc. in 2014 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 59 increasing their positions, 62 reducing their positions, and 18 closing their positions.
106% more first-time investments, than exits
New positions opened: 37 | Existing positions closed: 18
46% more call options, than puts
Call options by funds: $8.42M | Put options by funds: $5.76M
44% more capital invested
Capital invested by funds: $1.42B → $2.04B (+$620M)
10% more funds holding
Funds holding: 162 → 178 (+16)
6.19% more ownership
Funds ownership: 83.99% → 90.18% (+6.2%)
5% less repeat investments, than reductions
Existing positions increased: 59 | Existing positions reduced: 62
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
+$50.1M |
| 2 |
Morgan Stanley
New York
|
+$24.5M |
| 3 |
KCM
Kornitzer Capital Management
Shawnee Mission,
Kansas
|
+$22.7M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$21.1M |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
+$17M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RIM
RS Investment Management
San Francisco,
California
|
-$19.2M |
| 2 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
-$18.9M |
| 3 |
TGI
Tradewinds Global Investors
Los Angeles,
California
|
-$16M |
| 4 |
BC
Broadfin Capital
New York
|
-$15.6M |
| 5 |
NAP
New Amsterdam Partners
New York
|
-$14.6M |
IPXL Hedge Fund Activity: Q4 2014 in Review
178 of the 3,765 institutional investors tracked by Wall St. Rank reported a position in Impax Laboratories, Inc. (IPXL) for Q4 2014, worth a combined $2.04B — up 44% from $1.42B a quarter earlier.
Buyers outnumbered sellers: 37 funds opened new IPXL positions and 18 closed out — a net gain of 19 holders — while 59 added to existing stakes and 62 trimmed.
The largest buyer was Franklin Resources, adding an estimated $50.1M. The largest seller was RS Investment Management, exiting entirely with an estimated $19.2M sold.
- 178 institutional investors held Impax Laboratories, Inc. (IPXL) as of Q4 2014, up from 162 in Q3 2014.
- Funds reported $2.04B of Impax Laboratories, Inc. stock for Q4 2014, up 44% quarter-over-quarter.
- 37 funds opened new Impax Laboratories, Inc. positions in Q4 2014 and 18 closed out, a net change of +19 holders.
- The largest Impax Laboratories, Inc. buyer in Q4 2014 was Franklin Resources, an estimated $50.1M added.
- The largest Impax Laboratories, Inc. seller in Q4 2014 was RS Investment Management, an estimated $19.2M sold.
Based on aggregated 13F filings for Q4 2014.